Isabel Diebold
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
-
- Pulmonary Hypertension Research and Treatments
Papers in
-
- Metabolism and Genetic Disorders 6
-
- Cancer, Hypoxia, and Metabolism 6
- Co-authors
- Agnes GörlachJohn HessAndreas PetryRudi BusseRalf P. BrandesThomas KietzmannTalija DjordjevicValérie B. Schini‐Kerth
- Journals
- Circulation Research (3 papers)Circulation (3 papers)Thrombosis and Haemostasis (2 papers)Molecular Biology of the Cell (2 papers)Antioxidants and Redox Signaling (2 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Isabel Diebold
32 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 99
- Cancer Research 578
- Pulmonary and Respiratory Medicine 630
- Biochemistry 131
- Physiology 461
- Immunology 360
Countries citing papers authored by Isabel Diebold
This map shows the geographic impact of Isabel Diebold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Diebold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Diebold more than expected).
Fields of papers citing papers by Isabel Diebold
This network shows the impact of papers produced by Isabel Diebold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Diebold. The network helps show where Isabel Diebold may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Isabel Diebold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2022 | 1 | |
| 3 | 2021 | 4 | |
| 4 | 2021 | 10 | |
| 5 | 2021 | 4 | |
| 6 | 2020 | 8 | |
| 7 | 2020 | 1 | |
| 8 | 2019 | 18 | |
| 9 | 2018 | 23 | |
| 10 | 2018 | 17 | |
| 11 | 2015 | 102 | |
| 12 | 2015 | 176 | |
| 13 | 2012 | 137 | |
| 14 | 2012 | 57 | |
| 15 | 2011 | 94 | |
| 16 | 2011 | 49 | |
| 17 | 2010 | 61 | |
| 18 | 2009 | 49 | |
| 19 | 2008 | 56 | |
| 20 | Activation of hypoxia-inducible factor-1 is modulated by Rac1 in endothelial cells | 2000 | 1 |
About Isabel Diebold
Isabel Diebold is a scholar working on Clinical Biochemistry, Cancer Research, Cardiology and Cardiovascular Medicine, Immunology and Hematology, having authored 33 papers that have together received 2.1k indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (6 papers), Cancer, Hypoxia, and Metabolism (6 papers), Metabolism and Genetic Disorders (6 papers), Pulmonary Hypertension Research and Treatments (6 papers), Genomics and Rare Diseases (4 papers), Nitric Oxide and Endothelin Effects (4 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (3 papers). The work is most often cited by research in Cancer Research (578 citations), Pulmonary and Respiratory Medicine (630 citations), Biochemistry (131 citations), Physiology (461 citations) and Immunology (360 citations). Isabel Diebold has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Agnes Görlach, John Hess, Andreas Petry, Rudi Busse, Ralf P. Brandes, Thomas Kietzmann, Talija Djordjevic, Valérie B. Schini‐Kerth, U Roth and Utta Berchner‐Pfannschmidt. Their work appears in journals such as Circulation Research, Circulation, Thrombosis and Haemostasis, Molecular Biology of the Cell and Antioxidants and Redox Signaling.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.